Key Inclusion Criteria:~* Willing and able to comply with the study protocol and complete all aspects of the
study \[including cognitive and functional assessments, physical and neurological examinations, MRI, CSF
collection, genotyping, and positron emission tomography (PET) imaging\].~* Cognitively unimpaired with a
screening clinical dementia rating global score (CDR-GS) of 0, and Repeatable Battery for the Assessment of
Neuropsychological Status Delayed Memory Index (RBANS DMI) â‰¥80.~* Evidence of cerebral amyloid accumulation.~*
Participants who have an available person (referred to as a study partner).~* Fluent in the language of the
tests used at the study site.~* Adequate visual and auditory acuity, sufficient to perform neuropsychological
testing (eye glasses and hearing aids are permitted).~* Agreed not to participate in other interventional
research studies for the duration of this trial.~* For women of childbearing potential: agreement to remain
abstinent (refrain from heterosexual intercourse) or use contraceptive methods that result in a failure rate of
<1% per year during the treatment period and for at least 17 weeks after the final dose of study treatment.~Key
